Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $225.58M | $180.27M | 53.77% | -$45.32M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $79.27M | $76.89M | 22.93% | -$2.39M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $67.87M | $55.12M | 16.44% | -$12.74M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $23.86M | $22.98M | 6.85% | -$881.6K |
| Merus N V | 1,169,028 | 0 | -1,169,028 | $52.64M | $0 | — | -$52.64M |